Overview

A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

This is an open-label, randomized, cross-over, active-controlled study to evaluate the efficacy and safety effects using Meptin® Swinghaler and Berotec N® Metered Aerosol in stable asthma patients

Phase:

Phase 3

Details

Lead Sponsor:

Taiwan Otsuka Pharm. Co., Ltd

Treatments:

Fenoterol